Causal Effects Between Neurodegenerative Diseases, Metabolites, and Brain Volume

Nervonoylcarnitine and 1-linoleoyl-2-arachidonoyl-GPC may mediate the predicted effects of AD and LBD on hippocampal volumes, while the ratio of retinol to linoleoyl-arachidonoyl- glycerol mediates only LBD.

Authors

Institutions

Publication Details

Journal
Current Alzheimer Research
Published
2026-01-21
DOI
https://doi.org/10.2174/0115672050413060251107021634
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causal Effects Between Neurodegenerative Diseases, Metabolites, and Brain Volume

Sarah Hescham, Hans Clusmann, Yasin Temel, Hengjian Liu et al.
Current Alzheimer Research
Alzheimer's disease research and treatments
article

Causal Effects Between Neurodegenerative Diseases, Metabolites, and Brain Volume

Sarah Hescham, Hans Clusmann, Yasin Temel, Hengjian Liu, Dennis van der Meer
article en

Abstract

Nervonoylcarnitine and 1-linoleoyl-2-arachidonoyl-GPC may mediate the predicted effects of AD and LBD on hippocampal volumes, while the ratio of retinol to linoleoyl-arachidonoyl- glycerol mediates only LBD.

Current Alzheimer ResearchVol. 23
Oslo University Hospital (NO), Maastricht University Medical Centre (NL), European Graduate School of Neuroscience (NL), RWTH Aachen University (DE)
Openalex Percentile: Top 77%
Alzheimer's disease research and treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.